Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing [5]

Clinical Genetics

Volumn 70, Issue 1, 2006, Pages 80-82

  Yap, K P L ^a   Ang, P ^a   Lim, I H K ^a   Ho, G H ^a   Lee, Ana S G ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; GENOMIC DNA;

BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CHINESE; FAMILY HISTORY; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC COUNSELING; GENETIC RECOMBINATION; GENETIC RISK; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; LETTER; OVARY CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ADULT; ALU ELEMENTS; BASE SEQUENCE; BREAST NEOPLASMS; CHINA; DNA, NEOPLASM; EXONS; FEMALE; GENE REARRANGEMENT; GENES, BRCA1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; OVARIAN NEOPLASMS;

EID: 33746907114     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00637.x     Document Type: Letter

References (22)

1. Petrij-Bosch A, Peelen T, van Vliet M et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997: 17 (3): 341-345.
2. Montagna M, Dalla Palma M, Menin C et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003: 12 (9): 1055-1061.
3. Puget N, Stoppa-Lyonnet D, Sinilnikova OM et al. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 1999: 59 (2): 455-461.
4. Gad S, Klinger M, Caux-Moncoutier V et al. Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families. J Med Genet 2002: 39 (11): 817-821.
5. Hofmann W, Gorgens H, John A et al. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat 2003: 22 (1): 103-104.
6. Belogianni I, Apessos A, Mihalatos M et al. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 2004: 4 (1): 61.
7. Woodward AM, Davis TA, Silva AG et al. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian caEcer phenotype in selected families. J Med Genet 2005: 42 (5): e31.
8. Lahti-Domenici J, Rapakko K, Paakkonen K et al. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet 2001: 129 (2): 120-123.
9. Tang NL, Pang CP, Yeo W et al. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst 1999: 91 (10): 882-885.
10. Suter NM, Ray RM, Hu YW et al. BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 2004: 13 (2): 181-189.
11. Chen ST, Chen RA, Kuo SJ et al. Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan. Breast Cancer Res Treat 2003: 77 (2): 133-143.
12. Ho GH, Phang BH, Ng IS et al. Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years. Cancer 2000: 89 (4): 811-816.
13. Sng JH, Chang J, Feroze F et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 2000: 82 (3): 538-542.
14. Sellner LN, Taylor GR. MLPA and MAPH: New techniques for detection of gene deletions. Hum Mutat 2004: 23 (5): 413-419.
15. Wehner M, Mangold E, Sengteller M et al. Hereditary nonpolyposis colorectal cancer: Pitfalls in deletion screening in MSH2 and MLH1 genes. Eur J Hum Genet 2005: 13 (8): 983-986.
16. BRCA1 Exon 13 Duplication Screening Group. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000: 67 (1): 207-212.
17. Puget N, Sinilnikova OM, Stoppa-Lyonnet D et al. An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation? Am J Hum Genet 1999: 64 (1): 300-302.
18. Ward BD, Hendrickson BC, Judkins T et al. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 2005: 7 (1): 139-142.
19. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005: 25 (5): 415-422.
20. Hartmann C, John AL, Klaes R et al. Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 2004: 24 (6): 534.
21. Rudiger NS, Gregersen N, Kielland-Brandt MC. One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. Nucleic Acids Res 1995: 23 (2): 256-260.
22. Walsh T, Casadei S, Coats KH et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006: 295 (12): 1379-1388.